Stable isotope compounding services
Active Purchase Order Awarded Last action
- Contract number
- W81XWH22P0014
- Awardee
-
A & J Compounding, Inc. UEI CMLRB1G63M35
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $57,310
Award facts
- Opportunity
-
- W81XWH22Q0012 Solicitation number
- Contract value 64% obligated
-
- $58,760.00 Current, with exercised options
- $89,640.00 Potential, with all options
- Completion date 88% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Natick, MA 01760, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $9,040 | |
| Supplemental Agreement for work within scope | $4,850 | |
| Exercise an Option | $15,090 | |
| Funding Only Action | -$23,315 | |
| Exercise an Option | $18,405 | |
| Other Administrative Action | $16,110 | |
| Original award | $17,130 |
About this award
A & J Compounding, Inc. (UEI: CMLRB1G63M35) was awarded a firm fixed-price purchase order valued at $89,640 by the U.S. Army Medical Command for stable isotope compounding services. The contract was awarded on January 14, 2022, with an ultimate completion date of June 14, 2027. Performance will take place in Natick, Massachusetts. No set-aside designation was applied to this procurement.
Stable isotope compounding services support critical medical and scientific applications, including diagnostic imaging, research, and pharmaceutical development. The Army Medical Command's selection of A & J Compounding, Inc. for this requirement indicates the contractor's capability to produce specialized pharmaceutical compounds containing stable isotopes to specification. The extended performance period through mid-2027 suggests an ongoing requirement for these specialized compounding services to support military medical operations and research initiatives.
Quick answers
Who was awarded contract W81XWH22P0014?
W81XWH22P0014 was awarded to A & J Compounding, Inc. by Defense Health Agency (Department of Defense) on January 14, 2022.
How much is contract W81XWH22P0014 worth?
The government has obligated $57,310 on W81XWH22P0014. Its current value, with exercised options, is $58,760. Its potential value, with all options, is $89,640.
Which agency awarded contract W81XWH22P0014?
Defense Health Agency (Department of Defense) awarded W81XWH22P0014, with funding from Medical Command (Department of the Army).
Was contract W81XWH22P0014 competed?
The extent of competition for W81XWH22P0014 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award